This week, we find many medical and healthcare industry conferences announcing cancellations, postponements, and moves to virtual conferences to prevent the spread of COVID-19. The fear is that healthcare industry attendees may inadvertently return to their workplaces bearing COVID-19 and spread the infection. President Trump has signed a preparedness and prevention bill to apportion $300 ...
In this week’s Innovation Partners BioBlog, we look at the top stories from the world of healthcare. Eli Lilly reassured its customers that its drug supply, especially its stock of insulin, remains safe and unaffected by the COVID-19 outbreak. The Supreme Court has agreed to hear a case brought by 18 states against the legality ...
In this week’s Innovation Partners BioBlog, we report on health insurers profit with UnitedHealth the most profitable followed by CVS. Oscar Health is taking the extraordinary step of offering 100 medications at $3 each to encourage patients to continue taking much-needed medicines for chronic health conditions. New research into breast cancer shows that cancer cells ...
The American Society of Clinical Oncology’s Genitourinary Cancers Symposium provides several top stories this week including a promising combination therapy from Bristol-Myers Squibb and an announcement from Mustang Bio. The FDA announced they are halting inspections of Chinese plants due to the COVID-19 (coronavirus) outbreak and also warned against potential medical supply chain disruptions as ...
This week’s Innovation Partners BioBlog looks at ideas shaping the future of healthcare. Trump’s new budget includes four items that, although unlikely to pass through Congress, give a glimpse into the president’s priorities. Oncology biosimilars are on the rise with physicians starting new patients on them more often than in the past. And ASCO lauds ...
World Cancer Day, February 4, 2020, was marked by many organizations releasing updates, news, and guidelines. WHO urged nations to improve cancer care protocols for their citizens. NCCN recognized progress but reminded the world that cancer remains the second leading cause of death. This and more in this week’s Innovation Partners BioBlog. Insurers: Price transparency ...
In this edition of the Innovation Partners BioBlog, several promising cancer treatments are in the spotlight. CMS approves Medicare coverage of NGS tests for inherited ovarian and breast cancer. A new team supported by $3 million in grants seeks earlier detection methods for gastric cancer. Blue Cross Blue Shield and Civica RX announced the launch ...
This week, new treatments for liver, prostate, and lung cancer are featured in the Innovation Partners BioBlog. Each offers hope and a promising development in the development of oncology treatments. The Supreme Court is urged to take another look at the Texas appeals court ruling on the ACA, and two Trump administration healthcare policies are ...
This week’s Innovation Partners BioBlog takes a look at several important stories. California Governor Newsom announced a plan to work with generic drug makers to lower costs of medications for residents. New therapies for ovarian cancer and high cholesterol are in the works. A look at the potential 2020 mergers and acquisitions field makes an ...
You’ve heard the expression “all things old are new again” and it applies to cancer therapies, too. Drug developers are testing antibody-drug conjugates again. German manufacturer Boehringer has been clear to manufacture drugs in China, passing Chinese regulatory hurdles. The ACA is in the spotlight again with 20 states asking the Supreme Court to make ...
